Home » Posts tagged with » United Kingdom
PerkinElmer to acquire TB test kit maker Oxford Immunotec for $591m

PerkinElmer to acquire TB test kit maker Oxford Immunotec for $591m

US medical diagnostic firm PerkinElmer has agreed to acquire Oxford Immunotec Global, a UK-based diagnostics company, for $22 per share or around $591 million. Oxford Immunotec is engaged in developing test kits for latent tuberculosis. The company’s Interferon Gamma Release Assay (IGRA) offering is used for detecting tuberculosis. As of 30 September 2020, Oxford Immunotec […]

Sanofi to acquire UK-based biopharma company Kymab in $1.4bn worth deal

Sanofi acquisition of Kymab : French pharma giant Sanofi has signed a deal worth up to $1.45 billion to acquire Kymab, a UK-based clinical-stage biopharma company focused on developing fully human monoclonal antibodies, particularly for immune-mediated diseases, and immuno-oncology therapeutics. The consideration includes an upfront payment of around $1.1 billion and up to $350 million […]

Continue reading …
PharmaEngine, Sentinel Oncology partner to advance SOL-578 Chk1 inhibitor

PharmaEngine has signed a collaboration and license deal with UK-based Sentinel Oncology for advancing the new drug development of SOL-578, a checkpoint kinase 1 inhibitor (Chk1 inhibitor). As per the agreement, the Taiwanese pharma company will finance the investigational new drug (IND) enabling studies for SOL-578. Sentinel Oncology is a drug discovery company engaged in […]

Continue reading …
UK authorizes Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine

The UK has given a temporary authorization for emergency use for the BNT162b2 Covid-19 vaccine candidate developed by Pfizer and BioNTech. The emergency use authorization (EUA) from the UK Medicines & Healthcare Products Regulatory Agency (MHRA) for the mRNA vaccine candidate follows the release of positive results of a global phase 3 trial. Pfizer and […]

Continue reading …
NaQuinate : Haoma Medica completes human trial of osteoporosis candidate

Haoma Medica has wrapped up a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as an oral treatment for osteoporosis. The UK-based biotech company initiated the human trial of NaQuinate last year in healthy adults for assessing its single and multiple doses. The primary goal of the trial was to evaluate […]

Continue reading …
PostEra, NeuroLucent to partner on identifying small-molecule therapeutics for Alzheimer’s

PostEra, a UK-based biotech company, has entered into a collaboration with NeuroLucent, a US company focused on developing drugs for the treatment of Alzheimer’s disease and other dementias. NeuroLucent is currently developing novel small molecule compounds that normalize a key calcium channel that is dysregulated in Alzheimer’s disease’s neurons and restore normal neuronal function in […]

Continue reading …
PerkinElmer to acquire cell engineering company Horizon Discovery

US-based PerkinElmer will acquire UK-based cell engineering company Horizon Discovery Group for nearly $383 million in an all-cash deal. The transaction, which is subject to the meeting of customary closing conditions, expected to be completed in Q1 2021. Through the deal, PerkinElmer will expand its portfolio of automated life sciences discovery and applied genomics solutions […]

Continue reading …
Exact Sciences to acquire Thrive Earlier Detection for $2.15bn

Exact Sciences, a US molecular diagnostics company, has agreed to acquire Thrive Earlier Detection in a cash cum stock deal worth up to $2.15 billion, in a move to become a leading player in blood-based, multi-cancer screening. Based in Cambridge and Baltimore, Thrive Earlier Detection is a healthcare company focused on incorporating earlier cancer detection […]

Continue reading …
Oxford develops rapid diagnostic test to detect Covid-19 within 5mins

Oxford University claimed that scientists from its Physics department have developed an extremely rapid diagnostic test for Covid-19. The rapid diagnostic test can detect and identify viruses within five minutes, said the UK-based university. The method can be used to differentiate the SARS-CoV-2 virus from negative clinical samples and also from other common respiratory pathogens […]

Continue reading …
Novavax begins phase 3 trial of NVX-CoV2373 COVID-19 vaccine candidate

Novavax has initiated its first phase 3 clinical trial to assess the efficacy, safety, and immunogenicity of its NVX-CoV2373 COVID-19 vaccine candidate. The US vaccine development company is carrying out the late-stage trial in the UK in partnership with the UK government’s Vaccines Taskforce. The phase 3 trial of NVX-CoV2373 will aim to enroll and […]

Continue reading …
Page 1 of 41234